As highlighted earlier, the Phase 2 clinical trials demonstrated unprecedented mean body weight reductions, indicating its superior efficacy compared to existing monotherapies
Protecting muscle protects your results
The answer isn't a simple yes or no, as the comparison involves a few key factors: efficacy, tolerability, and access
Together, these peptides create a comprehensive anti-aging approach: GHK-CU addresses visible signs of aging through tissue regeneration and skin health, while Epithalon works at the cellular level to support healthspan and biological age optimization
Additional Information Payment Terms L/C, D/A, D/P, T/T, Western Union Delivery Time2 - 3 days Interested in this product
The study used a randomized, 3-period crossover design in ~54 participants, with a single 5 mg dose given in each period at different sites (abdomen, thigh, upper arm) separated by washouts